Latest Breaking News On - Albert weber - Page 4 : comparemela.com

CORRECTION – OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

CORRECTION – OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Oliver schachtOliver schachtpresidentCuretis gmbAlbert weberExchange commissionInternational numberTechnology platformFoundation for innovative new diagnosticsGene panelOpgen investor press contactAlyssa factoredison groupEuropean investment bankSecurities exchangeOpgen incFull yearChief financial officer

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

Curetis gmbAlbert weberOliver schachtEuropean investment bankInternational numberExchange commissionSecurities exchangeTechnology platformOpgen incFoundation for innovative new diagnosticsGene panelOpgen investor press contactEdison groupFull yearChief financial officerBeijing clear biotech

OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Total revenue for 2022 was approximately $2.6 millionBalance sheet strengthened by recently closed public offering with gross proceeds of $7.5 millionConference call to be held March. | March 29, 2023

Curetis gmbOliver schachtAlbert weberGene panelInternational numberFoundation for innovative new diagnosticsEuropean investment bankSecurities exchangeOpgen investor press contactTechnology platformOpgen incExchange commissionEdison groupFull yearChief financial officerBeijing clear biotech

Stock Market | FinancialContent Business Page

Albert weberOliver schachtCuretis gmbTechnology platformOpgen investor press contactGene panelOpgen incEdison groupFoundation for innovative new diagnosticsSecurities exchangeEuropean investment bankExchange commissionInternational numberFull yearChief financial officerBeijing clear biotech

OpGen, Inc (NASDAQ:OPGN) Q3 2022 Earnings Call Transcript

Operator: Welcome to the OpGen Third Quarter 2022 Earnings Call and Business Update. Today, OpGen management will provide an update on the company s current business and outlook for the future.

United statesAlbert weberOliver schachtBelgian national reference centerOpgen incThermo fisherExchange commissionNational association of corporate directorsYork state department of healthChina national medical productsEuropean investment bankUs centerCall transcript novemberOpgen third quarterAlyssa factorAlbert weaver